Adherium (ASX:ADRDA) ROCE % : -153.29% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Adherium ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Adherium's annualized ROCE % for the quarter that ended in Dec. 2023 was -153.29%.

Adherium ROCE % Historical Data

The historical data trend for Adherium's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adherium ROCE % Chart

Adherium Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

ROCE %

Get a 7-Day Free Trial

-172.87

-417.47

-146.97

-121.71

-144.66

Adherium Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial										-83.73	-169.65	-135.61	-70.76	-153.29

Adherium ROCE % Calculation

Adherium's annualized ROCE % for the fiscal year that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jun. 2023 )		(A: Jun. 2022 )		(A: Jun. 2023 )
	=	-9.852	/	( ( (7.36 - 2.953)	+	(12.681 - 3.467) )	/ 2 )
	=	-9.852	/	( (4.407	+	9.214)	/ 2 )
	=	-9.852	/	6.8105
	=	-144.66 %

Adherium's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-10.606	/	( ( (12.681 - 3.467)	+	(7.23 - 2.606) )	/ 2 )
	=	-10.606	/	( ( 9.214	+	4.624 )	/ 2 )
	=	-10.606	/	6.919
	=	-153.29 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Adherium (ASX:ADRDA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Adherium ROCE % Related Terms

Thank you for viewing the detailed overview of Adherium's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Adherium (ASX:ADRDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Adherium Ltd (ASX:ADRDA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 Collins Street, Level 14, Melbourne, VIC, AUS, 3000

Website

https://www.adherium.com

Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. Geographically, it derives a majority of its revenue from Europe and also has a presence in New Zealand and Australia; North America, and Asia.

Adherium (ASX:ADRDA) Headlines

No Headlines